Tirzepatide

Tirzepatide – 20mg / 30mg / 60mg Vial

Tirzepatide is a compounded injectable medication designed for medical weight loss. It acts as a dual GIP and GLP-1 receptor agonist, enhancing metabolic control and appetite regulation.

Tirzepatide

  • Dual GIP/GLP-1 receptor agonist for powerful weight loss and metabolic improvement
  • Can reduce body weight by 20% or more in clinical studies
  • Slows gastric emptying to prolong satiety
  • Gentle on the stomach with less nausea than single-agonist GLP-1 drugs
  • Improves blood sugar control and insulin sensitivity
  • Once-weekly injection for convenience

Protocols:

  • Start at the lowest dose to minimize side effects
  • Increase gradually following titration schedule
  • Inject on the same day each week for consistency

 

Injection Type
Subcutaneous (SubQ) injection

 

Recommended Dose

  • Start at 2.5 mg once weekly (week 1–4)
  • Gradually increase to 15 mg once weekly as tolerated
  • Dose in units depends on your vial concentration — use your mg/mL math to calculate exact units
  • Administer at the same time and day each week

 

Frequency

  • Once weekly

 

How to Increase the Dose (Titration Schedule)

  • Weeks 1–4: 2.5 mg once weekly
  • Weeks 5–8: Increase to 5 mg once weekly if well-tolerated
  • Weeks 9–12: Increase to 7.5 mg once weekly
  • Weeks 13–16: Increase to 10 mg once weekly
  • Weeks 17–20: Increase to 12.5 mg once weekly
  • Weeks 21+ (Maintenance): Up to 15 mg once weekly if needed for optimal results

Tirzepatide 20MG/2ML Vial 

Dose (mg)

Insulin Units

1.0 mg

10 units

2.0 mg

20 units

3.0 mg

30 units

4.0 mg

40 units

5.0 mg

50 units

6.0 mg

60 units

7.0 mg

70 units

8.0 mg

80 units

9.0 mg

90 units

 

Tirzepatide 30MG/3ML Vial 

Dose (mg)

Insulin Units

1.0 mg

10 units

2.0 mg

20 units

3.0 mg

30 units

4.0 mg

40 units

5.0 mg

50 units

6.0 mg

60 units

7.0 mg

70 units

8.0 mg

80 units

9.0 mg

90 units

 

Tirzepatide 60MG/2ML Vial 

Dose (mg)

Insulin Units

3.0 mg

10 units

6.0 mg

20 units

9.0 mg

30 units

10 mg

33 units

12  mg

40 units

Frequently Asked Questions

Tirzepatide is a once-weekly injectable medication that mimics two gut hormones (GLP-1 and GIP) to help regulate blood sugar, reduce appetite, and support weight loss. It’s FDA-approved for type 2 diabetes and used off-label for weight management.

It’s ideal for adults with type 2 diabetes, pre-diabetes, or those seeking medically supervised weight loss, especially when diet and exercise alone haven’t been effective.

Tirzepatide is given as a subcutaneous injection (under the skin) once per week, usually in the abdomen, thigh, or upper arm. We teach all patients how to self-inject safely at home.

Clinical studies show an average weight loss of 15–20% of total body weight with consistent use over several months, combined with healthy lifestyle habits.

Tirzepatide is typically prescribed for at least 4 to 6 months, and in some cases, longer depending on your weight loss or blood sugar goals.

Common side effects include nausea, constipation, diarrhea, decreased appetite, and mild fatigue. These usually improve as your body adjusts.

Schedule Your Botox And Filler Lab Consultation

You deserve to feel great about your appearance. At Botox And Filler Lab in Hallandale Beach, we use cutting-edge anti-aging treatments to help your face reflect your true self, whether in the mirror or photos. Schedule your consultation today and let us transform your look into a masterpiece you’ll love to share.

Get in touch

Leave your message, and we’ll get back to you shortly.

Contact

Monday - Saturday : 9AM - 7PM
Sunday : Close

© 2024 Botox And Filler Lab. All Rights Reserved.

Privacy Policy          Terms And Conditions

 

Pay Later With Cherry